However, in the multivariate regression model, including all significant factors, only vaginal atrophy remained significant.

Zinc levels of cervicovaginal lavage could be used as a new marker of vaginal atrophy.

We found significant differences between cervicovaginal lavage zinc level and age group, menopausal status, presence of vaginal dryness, and vaginal atrophy.

As well as relieving vasomotor symptoms, tibolone has positive effects on sexual well-being and mood, and improves vaginal atrophy and urogenital symptoms.

The FDA rejected Pfizer's bid to sell the once-a-day pill for osteoporosis in 2005 with the name Oporia and again in 2006 for vaginal atrophy.

This guidance refers to the long-term condition of urogenital atrophy.

This guidance refers to non-estrogen-based treatments for menopausal symptoms, such as hot flushes, symptoms of urogenital atrophy and lack of sexual desire.

Addressing identified knowledge deficits and practice barriers may lead to improved management of vulvovaginal atrophy.

Conclusions: Primary care and gynecology clinicians differ in their knowledge and confidence in managing vulvovaginal atrophy but report similar practice barriers.

Objective: Vulvovaginal atrophy is a common, but under-recognized condition affecting postmenopausal women.

Background and objectives: Most recently vaginal laser treatment was introduced as a new option for women with genitourinary syndrome of menopause, vaginal dryness.